There were 1,401 press releases posted in the last 24 hours and 401,378 in the last 365 days.

New Study Shows "Buzzy" Is An Easy-To-Implement Intervention To Reduce Vaccination Pain

Adding to over 20 studies showing the efficacy of using Buzzy, this new study highlights the ease of using Buzzy.

Reducing pain and fear saves lives - this study shows it takes less than a minute for significant pain reduction.”
— Amy Baxter MD, Founder & CEO

ATLANTA, GEORGIA, UNITED STATES, January 29, 2018 /EINPresswire.com/ -- MMJ Labs LLC, industry leader in non-pharmaceutical pain relief and creator of Buzzy® Drug-Free Pain Relief, is pleased to share findings from the latest independent study demonstrating the efficacy of Buzzy. MMJ Labs’ award-winning Buzzy® device has blocked pain from over 31 million needle procedures. With months remaining in this severe influenza season, there is still more work to do.

Since 2009, more than 20 research studies have shown that using Buzzy significantly reduces pain associated with various medical procedures, including IV placement, vaccinations, injections, and blood draws. This most recently released study of vaccine patients ages 3 - 18 resulted in pain scores that were "significantly lower" than the group receiving no intervention. Study authors observed, "[t]he Buzzy device is an easy to implement intervention to reduce pediatric pain during vaccination."

This latest study underscores new findings emphasizing why vaccine pain control matters:

(1) Vaccination is a significant source of pain for pediatric patients

(2) Vaccination pain results in fear of medical procedures, which is associated with future reluctance to seek medical care and the decision to vaccinate children

(3) Medical providers can provide fast pain prevention during these procedures

We know that 23% of adults avoid vaccinations due to fear. According to the Centers for Disease Control, 10,000 deaths each year could be prevented by vaccination. The simple intervention of blocking pain and fear could save 2,300 lives a year!

In unpublished data from a national pharmacy chain, 84% of adults felt no pain when Buzzy was used with their flu shot. For future shots, nearly half (45%) said they would choose their pharmacy based on who offered Buzzy. Offering pain relief to improve vaccination has never been easier.

MMJ Labs is especially pleased to see Buzzy characterized as "easy to implement" in medical practices. Reflecting on this latest study, Dr. Baxter explains, "Multiple studies show Buzzy blocks pain; this study is the first to show it takes less than a minute per patient for significant results." Buzzy is effective at relieving pain and easy to use in a clinical setting. It is also cost-effective and drug-free.

About MMJ LABS LLC

MMJ Labs is a woman owned and operated business headquartered at their Hive in Atlanta, Georgia. Established in 2006 by Dr. Amy Baxter, a pediatrician and pain researcher, MMJ Labs develops reusable, inexpensive physiologic products for personal pain control. Over a quarter million people have used the flagship product Buzzy®, a bee-shaped palm-sized device combining cold and vibration to combat needle pain. When placed between the brain and the pain, the competing stimulus controls or inhibits sharp pain. Additional pain solutions include DistrACTION® cards that reduce procedural pain through distraction, and VibraCool® Vibrating Cryotherapy. www.BuzzyHelps.com

Jennifer Tipping
MMJ Labs Pain Control Solutions
1.877.805.2899 x 707
email us here

Nationwide Childrens Flu Shot Video